ReviewJournal of cancer research and clinical oncology2023

The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review.

Jennifer R Landes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.